Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury

Kaplowitz, 2005, Idiosyncratic drug hepatotoxicity, Nat Rev Drug Discov, 4, 489, 10.1038/nrd1750 Lucena, 2009, Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex, Hepatology, 49, 2001, 10.1002/hep.22895 Kleiner, 2014, Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations, Hepatology, 59, 661, 10.1002/hep.26709 Björnsson, 2005, Outcome and prognostic markers in severe drug-induced liver disease, Hepatology, 42, 481, 10.1002/hep.20800 Andrade, 2005, Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 Robles-Diaz, 2014, Use of Hy’s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury, Gastroenterology, 147, 109, 10.1053/j.gastro.2014.03.050 Chalasani, 2008, Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States, Gastroenterology, 135, 1924, 10.1053/j.gastro.2008.09.011 Fontana, 2014, Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset, Gastroenterology, 147, 96, 10.1053/j.gastro.2014.03.045 Seeff, 1981, Drug-induced chronic liver disease, with emphasis on chronic active hepatitis, Semin Liver Dis, 1, 104, 10.1055/s-2008-1040723 Aithal, 1999, The natural history of histologically proved drug induced liver disease, Gut, 44, 731, 10.1136/gut.44.5.731 Björnsson, 2009, The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice, J Hepatol, 50, 511, 10.1016/j.jhep.2008.10.021 Benichou, 1990, Criteria of drug-induced liver disorders. Report of an International Consensus Meeting, J Hepatol, 11, 272, 10.1016/0168-8278(90)90124-A Andrade, 2006, Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry, Hepatology, 44, 1581, 10.1002/hep.21424 Fontana, 2009, Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct, Drug Saf, 32, 55, 10.2165/00002018-200932010-00005 Aithal, 2011, Case definition and phenotype standardization in drug-induced liver injury, Clin Pharmacol Ther, 89, 806, 10.1038/clpt.2011.58 Fontana, 2015, Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury, Am J Gastroenterol, 110, 1450, 10.1038/ajg.2015.283 2001, JAMA, 285, 2486, 10.1001/jama.285.19.2486 2014 Danan, 1993, Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 Björnsson, 2007, Long-term follow-up of patients with mild to moderate drug-induced liver injury, Aliment Pharmacol Ther, 26, 79, 10.1111/j.1365-2036.2007.03355.x Williams, 2012, Role of innate and adaptive immunity during drug-induced liver injury, Toxicol Res, 1, 161, 10.1039/c2tx20032e Reuben, 2010, Drug-induced acute liver failure: results of a U.S. multicenter, prospective study, Hepatology, 52, 2065, 10.1002/hep.23937 Lucena, 2011, Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis, J Hepatol, 55, 820, 10.1016/j.jhep.2010.12.041 Andrade, 1999, Acute liver injury associated with the use of ebrotidine, a new H2-receptor antagonist, J Hepatol, 31, 641, 10.1016/S0168-8278(99)80343-2 Pineda, 1999, Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine, J Hepatol, 31, 777, 10.1016/S0168-8278(99)80362-6 Andrade, 2000, Chronic liver injury related to use of bentazepam: an unusual instance of benzodiazepine hepatotoxicity, Dig Dis Sci, 45, 1400, 10.1023/A:1005520523502 Perdices, 2014, Hepatotoxicity associated with statin use: analysis of the cases included in the Spanish Hepatotoxicity Registry, Rev Esp Enferm Dig, 106, 246 Luparini, 2000, Possibly ranitidine-induced autoimmune hepatitis, Ann Ital Med Int, 15, 214 Black, 1975, Isoniazid-associated hepatitis in 114 patients, Gastroenterology, 69, 289, 10.1016/S0016-5085(19)32568-5 Sharp, 1980, Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin, Ann Intern Med, 92, 14, 10.7326/0003-4819-92-1-14 Amit, 2002, Nitrofurantoin-induced chronic active hepatitis, Isr Med Assoc J, 4, 184 Stricker, 1988, Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases, Hepatology, 8, 599, 10.1002/hep.1840080327 Olsson, 1992, Liver damage from flucloxacillin, cloxacillin and dicloxacillin, J Hepatol, 15, 154, 10.1016/0168-8278(92)90029-O Oikawa, 2005, Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: a case report, World J Gastroenterol, 11, 5394, 10.3748/wjg.v11.i34.5394 Whiting-O’Keefe, 1991, Methotrexate and histologic hepatic abnormalities: a meta-analysis, Am J Med, 90, 711, 10.1016/S0002-9343(05)80060-9 Moradpour, 1994, Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis, Hepatology, 20, 1437, 10.1002/hep.1840200610 Yeung, 2003, Ramipril-associated hepatotoxicity, Arch Pathol Lab Med, 127, 1493, 10.5858/2003-127-1493-RH Mazeika, 1989, Chronic active hepatitis associated with diclofenac sodium therapy, Br J Clin Pract, 43, 125, 10.1111/j.1742-1241.1989.tb08690.x Clarke, 2006, Atorvastatin associated liver disease, Dig Liver Dis, 38, 772, 10.1016/j.dld.2006.04.013 Russo, 2014, Spectrum of statin hepatotoxicity: experience of the drug-induced liver injury network, Hepatology, 60, 679, 10.1002/hep.27157 Yao, 1997, Trimethoprim sulfamethoxazole-induced vanishing bile duct syndrome, Am J Gastroenterol, 92, 167 Kowdley, 1992, Prolonged cholestasis due to trimethoprim sulfamethoxazole, Gastroenterology, 102, 2148, 10.1016/0016-5085(92)90346-Z Chalasani, 2015, Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study, Gastroenterology, 148, 10.1053/j.gastro.2015.03.006 Chatrenet, 1993, Chronic active cirrhogenic hepatitis induced by fenofibrate, Gastroenterol Clin Biol, 17, 612 Ghabril, 2014, Drug-induced nodular regenerative hyperplasia, Semin Liver Dis, 34, 240, 10.1055/s-0034-1375963 Anania, 2002, Terbinafine hepatotoxicity resulting in chronic biliaryductopenia and portal fibrosis, Am J Med, 112, 741, 10.1016/S0002-9343(02)01109-9 Gendre, 2008, Terbinafine induced hepatitis with persistent cholestasis, Rev Med Suisse, 4, 736